Last reviewed · How we verify
Verapamil Only Product in Oral Dose Form — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Verapamil Only Product in Oral Dose Form (Verapamil Only Product in Oral Dose Form) — Honeybrains Biotech LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Verapamil Only Product in Oral Dose Form TARGET | Verapamil Only Product in Oral Dose Form | Honeybrains Biotech LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Verapamil Only Product in Oral Dose Form CI watch — RSS
- Verapamil Only Product in Oral Dose Form CI watch — Atom
- Verapamil Only Product in Oral Dose Form CI watch — JSON
- Verapamil Only Product in Oral Dose Form alone — RSS
Cite this brief
Drug Landscape (2026). Verapamil Only Product in Oral Dose Form — Competitive Intelligence Brief. https://druglandscape.com/ci/verapamil-only-product-in-oral-dose-form. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab